ATX-LPA receptor axis in inflammation and cancer

 Abstract

Lysophosphatidic acid (LPA, 1- or 2-acyl-sn-glycerol 3-phosphate) mediates a plethora of physiological and pathological activities via interactions with a series of high affinity G protein-coupled receptors (GPCR). Both LPA receptor family members and autotaxin (ATX/LysoPLD), the primary LPA-producing enzyme, are aberrantly expressed in many human breast cancers and several other cancer lineages. Using transgenic mice expressing either an LPA receptor or ATX, we recently demonstrated that the ATX-LPA receptor axis plays a causal role in breast tumorigenesis and cancerrelated inflammation, further validating the ATX-LPA receptor axis as a rich therapeutic target in cancer.

Full Text Options
Article
Metrics
 Share
 Info
Pages
3695 - 3701
doi
10.4161/cc.8.22.9937
Type
Review
 Metrics
 Cite This Article
 Permissions
 Permissions
 Reprints
ATX-LPA receptor axis in inflammation and cancer